Health
The drug aprotinin inhibits entry of SARS-CoV2 in host cells, study finds – Science Daily
In order for the SARS-CoV2 virus to enter host cells, its ‘spike’ protein has to be cleaved by the cell’s own enzymes — proteases. The protease inhibitor aprotinin…
In order for the SARS-CoV2 virus to enter host cells, its “spike” protein has to be cleaved by the cell’s own enzymes — proteases. The protease inhibitor aprotinin can prevent cell infection, as scientists at Goethe University, the University of Kent and the Hannover Medical School have now discovered. An aprotinin aerosol is already approved in Russia for the treatment of influenza and could readily be tested for the treatment of COVID-19.The surface of the SARS-CoV-2 virus is studded with spike…
-
General13 hours agoFarmers develop ‘autofill’ tech so agricultural robots can operate around the clock
-
General15 hours agoTrump mulling whether to fire US Fed chair Powell
-
Noosa News19 hours agoRevealed: 75 Qld suburbs you could afford to buy in if lending standards drop
-
Noosa News19 hours agoNowhere is growing like this corner of Queensland. It’s changing the political game